Glanbia | GLB

Stock Price
14.50
Daily Change
-0.01 -0.07%
Monthly
19.83%
Yearly
-5.60%
Q3 Forecast
14.39

Peers Price Chg Day Year Date
Agrana Beteiligungs 11.60 -0.15 -1.28% -3.33% Sep/05
Austevoll Seafood 92.20 0.20 0.22% -0.54% Sep/05
British American Tobacco 4,133.00 3.00 0.07% 39.02% Sep/06
Beiersdorf 97.32 -1.58 -1.60% -23.97% Sep/06
Danone 75.08 0.10 0.13% 14.21% Sep/06
Givaudan 3,504.00 21.00 0.60% -20.53% Sep/05
Glanbia 14.50 -0.01 -0.07% -5.60% Sep/05
Henkel 74.08 0.20 0.27% -8.45% Sep/06
International Flavors Fragrances 66.03 0.50 0.76% -35.89% Sep/05
Imperial Brands 3,144.00 26.00 0.83% 39.30% Sep/06
Kerry 78.85 0.85 1.09% -14.66% Sep/05
Nestle 75.41 -0.48 -0.63% -13.86% Sep/05
Origin Enterprises 3.86 0 0% 14.20% Sep/05
Reckitt Benckiser 5,710.00 32.00 0.56% 27.28% Sep/06
Tate & Lyle 512.00 -2.50 -0.49% -25.04% Sep/05
Unilever 4,769.00 -32.00 -0.67% -5.26% Sep/06
Viscofan 60.80 0.20 0.33% 0.33% Sep/05

Indexes Price Day Year Date
ISEQ 11306 61.03 0.54% 18.12% Sep/05
EU600 549 -0.88 -0.16% 8.42% Sep/05

Glanbia traded at 14.50 this Friday September 5th, decreasing 0.01 or 0.07 percent since the previous trading session. Looking back, over the last four weeks, Glanbia lost 19.83 percent. Over the last 12 months, its price fell by 5.60 percent. Looking ahead, we forecast Glanbia to be priced at 14.39 by the end of this quarter and at 14.05 in one year, according to Trading Economics global macro models projections and analysts expectations.

Glanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company's Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages. The Company's Glanbia Nutritionals segment provides nutritional solutions. It manufactures and sells cheese, dairy and non-dairy nutritional ingredients and vitamin and mineral premixes targeting the market focus on health and nutrition.